bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.11.07.686145

Assessing fish diversity in the Amazon: The impact of primers and reference libraries in eDNA surveys

Abstract

Selecting primers for DNA amplification poses a challenge in environmental DNA (eDNA) studies, particularly in biodiverse tropical ecosystems. Researchers must balance taxonomic coverage, primer specificity, and study feasibility when choosing between a single primer pair and multiple primer pairs. Empirical tests comparing these strategies are essential for improving eDNA protocols, enhancing the detection of aquatic biodiversity, and supporting conservation and environmental monitoring efforts. This study aimed to evaluate how different approaches affect the specificity and efficiency of detecting fish species in eDNA samples from the Teles Pires River basin. We (1) synthesized modified versions of primers commonly used in ichthyofaunal surveys; (2) compared the results generated by these modified primers with the standard primer versions; and (3) evaluated the species detection using two reference sequence databases: a global taxonomic database (GenBank) and a locally constructed taxonomic database containing samples of fish species previously collected in situ. The 12S-V5_mod primers detected the most fish species across the databases (67, 104, and 130 in the Midori2, Local, and joint databases, respectively), followed by the MiFish_mod primers, which detected 47, 101, and 114 species. Finally, the MiFish primers detected 39, 73, and 78 species. The 12S-V5_mod primers also had lower taxonomic specificity of fish species and amplified a broader range of vertebrate taxa than the MiFish_mod primers. The modified primers outperformed the MiFish primers, and detectability nearly doubled when the Local reference database was used. These results speak to the critical need for constructing reference databases of regional biodiversity, and the need to incorporate multiple primer pairs in eDNA studies.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Hashimoto, S., Carvalho, S. V., Miranda, S. d. S. C., Machado, V. N., Carvalho, L. N., Deus, C. P. d., Farias, I. P., Hrbek, T.. 2025-11-08. Assessing fish diversity in the Amazon: The impact of primers and reference libraries in eDNA surveys. https://doi.org/10.1101/2025.11.07.686145

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

OPA1 controls mitochondrial dysfunction-driven liver fibrosis in MASLD

Progressive hepatic fibrosis is the principal determinant of morbidity and mortality in metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD/MASH). Mitochondrial dysfunction is a hallmark of MASH, and the release of mitochondrial damage-associated molecular patterns (mito-DAMPs) from injured hepatocytes can promote fibrosis. However, how mitochondrial dynamics and quality control shape the fibrotic response in MASLD/MASH remains unclear. Here, through large-scale genomic analyses of mitochondrial genes governing mitophagy, fusion and fission in human MASLD, with a power-equivalent sample size of approximately 700,000 individuals, we identify a strong association between hepatic fibrosis and the mitochondrial fusion factor dynamin-like GTPase optic atrophy 1 (OPA1). OPA1 transcripts and protein abundance in the liver epithelium were progressively dysregulated with advancing fibrosis. In mice, hepatocyte-specific OPA1 loss alone was sufficient to induce hepatic stellate cell activation and fibrosis in zone 3, promoted the release of mito-DAMPs into the circulation and exacerbated fibrosis in experimental MASH. These findings identify OPA1 as a central regulator of the hepatic fibrotic response and connect defective mitochondrial homeostasis to mito-DAMP release, hepatic stellate cell activation and fibrosis in MASLD.

genetics↗

Temporal control of mitochondrial mutagenesis reveals the fate of mtDNA mutations with age

Mutations in the mitochondrial genome (mtDNA) play a critical role in the aging process and a wide variety of age-related diseases. However, it remains unclear when the mutations that drive physiological decline arise. To answer this question, we generated a new mouse model in which mitochondrial mutagenesis can be confined to a defined window of time. Surprisingly, we found that mutations that arise during the first two months of life are sufficient to drive a wide variety of age-related pathologies, and that the severity of this pathology is broadly regulated by distinct, tissue-specific selective pressures that control the fate of mtDNA mutations with age. Further, we found that selection against deleterious variants can be modulated by manipulation of mitochondrial fusion in vitro and in vivo. These observations raise the possibility that in some tissues, the pace of aging is pre-determined by events that occur early in life and that interventions targeting mitochondrial fusion may be able to slow down or reverse the expansion of these pathogenic variants. These results carry far-reaching implications for strategies aimed at preventing or delaying age-related decline.

genetics↗

Innate immune stress pathway activation underlies heterochromatin dysfunction pathology

Heterochromatin loss disrupts nuclear architecture, gene regulation and repetitive element silencing, and is associated with diverse human diseases. However, mechanisms linking heterochromatin dysfunction to pathological phenotypes remain unclear. Using genetic interaction screening and genomic analyses in C. elegans, we identify secondary activation of the Intracellular Pathogen Response (IPR), an innate immune stress pathway, as a major contributor to heterochromatin mutant phenotypes. Constitutive IPR activation phenocopies slow growth and indirect transcriptional changes observed in these mutants. Depletion of genetic enhancers further increased, whereas suppressor RNAi attenuated IPR activation, with direct heterochromatin targets remaining substantially deregulated. Notably, many suppressors encode active chromatin components, and mild reduction of RNA polymerase II activity ameliorates growth defects in C. elegans HP1 mutants and human HP1-deficient cells. Our findings reveal secondary stress response activation as an important mechanism linking heterochromatin dysfunction to pathology and identify transcriptional dampening as a potential therapeutic strategy for mitigating these effects.

genetics↗